For the quarter ending 2025-09-30, BFNH has $784 in assets. $500,722 in debts. $784 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 784 | 905 | ||
| Total current assets | 784 | 905 | ||
| Total assets | 784 | 905 | ||
| Accounts payable and accrued expenses | 10,709 | 10,466 | ||
| Accrued board of directors compensation | 421,800 | 317,249 | ||
| Due to related parties | 68,213 | 57,213 | ||
| Total current liabilities | 500,722 | 384,928 | ||
| Total liabilities | 500,722 | 384,928 | ||
| Common stock - 0.001 par 900,000,000 shares authorized, 33,521,755 and 29,271,755 issued and outstanding, respectively | 33,522 | 33,522 | ||
| Additional paid-in-capital | 161,760,052 | 161,760,052 | ||
| Accumulated deficit | -162,293,512 | -162,177,597 | ||
| Total stockholders' deficit | -499,938 | -384,023 | ||
| Total liabilities and stockholders' deficit | 784 | 905 | ||
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)